Hydrogen peroxide (H 2 O 2 ) has a major function in host-microbial interactions. Although most studies have focused on the endogenous H 2 O 2 produced by immune cells to kill microbes, bacteria can also produce H 2 O 2 . How microbial H 2 O 2 influences the dynamics of host-microbial interactions is unclear. Here we show that H 2 O 2 released by Streptococcus pneumoniae inhibits inflammasomes, key components of the innate immune system, contributing to the pathogen colonization of the host. We also show that the oral commensal H 2 O 2 -producing bacteria Streptococcus oralis can block inflammasome activation. This study uncovers an unexpected role of H 2 O 2 in immune suppression and demonstrates how, through this mechanism, bacteria might restrain the immune system to co-exist with the host.
H ydrogen peroxide (H 2 O 2 ) is a ubiquitous metabolic byproduct of aerobic unicellular and multicellular organisms 1-4 that plays a major role in determining the outcome of host-microbial interactions 5 . Thus far, studies have focused on endogenous H 2 O 2 produced by immune cells and its role in killing microbes or driving inflammatory processes 1, [5] [6] [7] [8] . However, H 2 O 2 generation is not a preserve of eukaryotic host cells-many microbes do produce H 2 O 2 1, 4 . How H 2 O 2 produced by microbes affect the dynamic of host-microbial interactions, and in particular the ability of immune cells to respond to microbes, remains unknown.
Accumulation of H 2 O 2 to high levels can be toxic to both the host and the microbe. To mitigate these undesired effects, most organisms are equipped with enzymes such as catalase to neutralize H 2 O 2 2 . However, some bacterial species lack catalase. One well-known example is S. pneumoniae. Consequently, a major hallmark of S. pneumoniae infection is massive production of H 2 O 2 , which can accumulate up to millimolars in in vitro cultures 9, 10 . Considering that up to ∼10 8 cfu/mL of S. pneumoniae has been documented in infected lungs 11 , it is likely that the concentration of H 2 O 2 in vivo, especially at the infection foci, is equally high hence can be detected in the breath of patients 12 .
While H 2 O 2 production is responsible for autolysis of bacteria at stationary phase, generally, S. pneumoniae is highly resistant to H 2 O 2 via mechanisms not fully understood 13, 14 . This resistance allows S. pneumoniae not only to outcompete other bacteria from the host niche but likely also to withstand H 2 O 2 produced by immune cells. But how H 2 O 2 produced by bacteria afffects the anti-microbial response of immune cells is unresolved.
Microbes-especially those that have established a longstanding co-existence with their hosts have evolved diverse mechanisms to mitigate anti-microbial innate immune defenses [13] [14] [15] . S. pneumoniae is a habitant of the upper respiratory tract and the most common causative agent of community-acquired pneumonia, a leading cause of death worldwide 16, 17 . Infections with S. pneumoniae possibly also promote invasion of the airways by other pathogens 16, 17 .
How S. pneumoniae overcomes the innate immune system to persist in the host has remained unclear. Here we reveal that S. pneumoniae actively inhibits inflammasomes-key components of the innate immune system. This contributes to its ability to colonize the host but also renders immune cells unresponsive to other inflammasome stimuli during co-infections. We demonstrate that this phenomenon is due to S. pneumoniae-generated H 2 O 2 , which causes oxidative inactivation of inflammasomes. Further, we show that other H 2 O 2 -producing bacteria such as Streptococcus oralis, an oral commensal, similarly block inflammasomes. This study uncovers an unanticipated role of microbial H 2 O 2 in innate immune suppression, and how this promotes host colonization by microbes.
Results
S. pneumoniae dampens inflammasome-dependent immunity via SpxB. The major source of H 2 O 2 generated by S. pneumoniae is via its pyruvate oxidase (SpxB) 9, [18] [19] [20] , which catalyzes the phosphate-dependent oxidation of pyruvate to form acetyl phosphate, CO 2 and H 2 O 2 (Fig. 1a ). SpxB has diverse and counter-intuitive effects on the host and the bacteria. While responsible for spontaneous bacterial lysis 19, 21 and promotion of phagocytic uptake 22 , SpxB confers survival fitness to S. pneumoniae in vivo 21 and contributes to resistance to oxidative stress 9 . Based on these divergent context-dependent effects of SpxB, we sought to investigate the impact of bacteria-derived H 2 O 2 on the interaction between S. pneumoniae and a murine host.
Whereas the SpxB-deficient S. pneumoniae strain D39 (S.p. ΔspxB) that is highly defective in H 2 O 2 production ( Fig. 1b ) exhibits a growth advantage over the wild-type strain in vitro ( Fig. 1c ), we find that upon intranasal inoculation in mice, S.p. ΔspxB causes severer clinical symptoms and is cleared faster without causing mortality ( Fig. 1d-f ). The severer symptoms and faster clearance of S.p. ΔspxB in vivo prompted us to investigate whether this mutant elicits a stronger anti-bacterial immune response. Indeed, although killed faster than wild-type S. pneumoniae D39 (S.p. WT) in vivo, S.p. ΔspxB elicits significantly higher levels of the inflammasome-dependent cytokine IL-1β ( Fig. 1g ). This is in contrast to the inflammasome-independent cytokine TNF-α, which, although showing a similar trend, is not significantly different between mice infected with wild-type or mutant bacteria (Fig. 1h ). These results indicate that in the absence of SpxB, S. pneumoniae activates a stronger anti-bacterial immunity and in particular an inflammasome-dependent innate immune response.
S. pneumoniae blocks inflammasomes via SpxB-generated H 2 O 2 . Inflammasomes are intracellular multiprotein complexes that control the activation of Caspase-1, mediating pyroptotic cell death and the maturation of IL-1 family cytokines that are essential for optimal defence against pathogens including S. pneumoniae [23] [24] [25] [26] . Generally, inflammasome activation involves two checkpoints: a priming step to induce the synthesis of pro-IL-1β and certain inflammasome components and a second step triggering the assembly and activation of inflammasome complexes 24 . To evaluate how S. pneumoniae modulates the second step of inflammasome activation, bone marrow-derived macrophages (BMDMs) were first primed with the TLR ligand lipopolysaccharide (LPS) and then infected with S. pneumoniae D39 for different durations. Thereafter, the magnitude and kinetics of Caspase-1 and IL-1β processing was compared with that by classical inflammasome activators. Here we show that although BMDMs infected with S. pneumoniae exhibit large amounts of pro-IL-1β and pro-Caspase-1, accumulation of the processed forms (IL-1β p17 and Casp-1 p20) is highly delayed and remains undetectable until 6 to 12 h post infection. Even at these delayed time points, the ratio of processed IL-1β and Caspase-1 to their precursors is very low ( Supplementary Fig. 1a -c). This is in clear contrast to stimulation with ATP or nigericin (agonists of the NLRP3 inflammasome), Salmonella Typhimurium or Pseudomonas aeruginosa (activators of the NLRC4 inflammasome) 27, 28 , which elicit robust processing of Caspase-1 and IL-1β within 30 to 60 min ( Supplementary Fig. 1d -g). This demonstrates that S. pneumoniae does not directly activate inflammasomes at the early stage of infection and that the weak response detected at later time points is likely a secondary outcome of danger signals such as ATP from dead or stressed cells or by pneumolysin extruded from lysed bacteria [29] [30] [31] [32] .
In view of these observations, we wondered whether such limited responses are due to inhibition of inflammasomes by S. pneumoniae. To directly test this idea, we pre-treated BMDMs with S.p. WT before challenging them with agonists for different inflammasomes including ATP, nigericin or P. aeruginosa (schematically illustration in Fig. 2a ). S.p. WT dose-dependently inhibits the processing and secretion of Caspase-1, IL-1β and IL-18 ( Fig. 2b-j) . In contrast, TNFα is unaltered ( Fig. 2k-m) .
As S.p. ΔspxB induces elevated IL-1β levels in vivo ( Fig. 1g ), we tested whether S. pneumoniae blocks inflammasomes via SpxB. Indeed, inflammasome activation by ATP and P. aeruginosa is highly inhibited in the presence of S.p. WT ( Fig. 3a -c) but not S.p. ΔspxB, except upon complementation with a plasmid carrying the spxB gene ( Fig. 3d, e ).
However, pre-infection of cells with S. pneumoniae does not inhibit the induction of Pro-IL-1β or TNFα by the TLR ligand LPS, thus ruling out priming as the target of S. pneumoniaemediated inflammasome inhibition ( Supplementary Fig. 2a-f ).
Further, LDH release and bacterial uptake assays show that the diminished inflammasome response is not due to loss of phagocytic activity or viability ( Supplementary Fig. 2g Supplementary Fig. 3 ). Together, these data demonstrate that S. pneumoniae actively blocks inflammasome activation. Next, we sought to determine the bacterial factors responsible for inflammasome activation by S. pneumoniae. Pneumolysin (PLY) is an intracellular thiol-dependent pore forming toxin released into the environment upon bacterial lysis 33, 34 . In view of previous studies [29] [30] [31] [32] 35, 36 , we compared the ability of S.p. WT and ply-deficient S. pneumoniae (S.p. Δply) to induce inflammasome activation. As observed before, short (1 h) infection with S.p. WT or S.p. Δply fail to induce inflammasome activation. However, long-term (12 h) infection lead to a modest response by S.p. WT but not S.p. Δply, confirming the importance of PLY in S. pneumoniae-mediated inflammasome activation (Supplementary Fig. 4a ). As a proxy to evaluate inflammasome activation by PLY and how this is affects by S. pneumoniae we used a highly purified listeriolysin O (LLO)-a homologous pore-forming toxin. LLO induces robust inflammasome activation that is inhibited by S.p. WT but not S.p. ΔspxB ( Supplementary  Fig. 4b-d ). Similar to PLY, LLO is a thiol-dependent toxin hence highly sensitive to oxidation 37 . Therefore, we employed catalase, an H 2 O 2 -neutralizing enzyme, to reduce the accumulation of reactive oxygen species. Treatment with catalase enhances LLO-mediated inflammasome activation and increases the ability of S.p. WT to induce inflammasome activation ( Supplementary  Fig. 4e , f). Hence, we concluded that the restrained inflammasome response elicited by S. pneumoniae is likely due to oxidative inactivation of host signaling molecules as well as the bacterial inflammasome agonist PLY.
Pro-Casp-1 - S. pneumoniae blocks the assembly of inflammasome complexes. ASC oligomerization is a critical step in the assembly and activation of inflammasome complexes 38, 39 . To test whether S. pneumoniae D39 affects this step, we employed differential centrifugation and chemical cross-linking 40 to isolate and analyze ASC oligomers. LPS-primed BMDMs pre-treated with S.p. WT exhibit severely impaired ASC oligomerization and diminished processing of Caspase-1 and IL-1β in response to ATP or P. aeruginosa. This is in contrast to S.p. ΔspxB-pre-treated cells that do not exhibit inhibited ASC oligomerization ( Fig. 4a, b ), except upon complementation with the plasmid carrying the spxB gene ( Supplementary Fig. 5a , b). To verify these findings, BMDMs were fluorescently labelled with the Caspase-1 fluorescent activity-based probe FLICA (FAM-YVAD-FMK) and an anti-ASC antibody and then analyzed microscopically for ASC/ Caspase-1 complexes (specks). BMDMs pre-treated with WT S. pneumoniae D39 exhibit highly reduced ASC/Caspase-1 speck formation in response to ATP or P. aeruginosa ( Fig. 4c-f ). To determine whether inflammasome inhibition is a general feature of S. pneumoniae, we tested other S. pneumoniae strains including A66.1 (serotype 3), TIGR4 (serotype 4), and the unencapsulated strain R6. All such strains inhibit ASC oligomerization and processing of Caspase-1 and IL-1β ( Supplementary Fig. 6a-d Fig. 7a-c) . Notably, catalase rescues inflammasome inhibition by S.p. WT (Fig. 6a, b and Supplementary Fig. 7d -o) and S. oralis, but has no effect on the IL-1β response by S. sobrinus or TNF-α production ( Supplementary Fig. 7d-o) . Moreover, S. pneumoniae is unable to block inflammasome activation in the presence of catalase in human PBMCs ( Supplementary Fig. 8a-h) . In contrast, inflammasome inhibition can be recapitulated by direct addition of H 2 O 2 to BMDMs (Fig. 6c, d ). Titration of the H 2 O 2 amount reveals that 50-100 µM H 2 O 2 are sufficient to inhibit Caspase -1 as well as Caspase -3 and Caspase -8 ( Supplementary  Fig 9a) . In contrast to S.p. ΔspxB, S.p. WT and the S.p. ΔspxB carrying the SpxB complementing plasmid release similarly high amounts of H 2 O 2 into the cell culture medium during infection ( Supplementary Fig. 9b, c) .
The above data unequivocally demonstrate that H 2 O 2 is a potent inhibitor of inflammasomes. This led us to hypothesize that such inhibition of inflammasomes is due to oxidation of inflammasome components. Protein carbonylation is the most general marker of severe oxidative protein damage. It involves covalent adduction of carbonyl groups (e.g. aldehydes and ketones) on oxidised side chains of susceptible amino acid residues such as cysteine, proline, arginine, lysine and threonine 41 . Carbonylated proteins can be labelled with dinitrophenylhydrazine and detected using anti-dinitrophenol (DNP) antibodies. Immunoblotting of DNP-derivatized cell extracts reveals increased protein carbonylation in macrophages exposed to S.p. WT ( Supplementary Fig. 10a, b) , indicating that H 2 O 2 production by S. pneumoniae causes oxidation of proteins in host cells. Given that oligomerization of ASC, a key inflammasome component, is impaired in the presence of S. pneumoniae or H 2 O 2 (Fig. 4, Fig. 6, Supplementary Fig. 5 and Supplementary  Fig 6) , we next tested whether ASC is among those proteins oxidised by S. pneumoniae. Immunoprecipitation and immunoblot analyses of DNP-derivatized cell extracts reveal that ASC is carbonylated upon exposure to WT S. pneumoniae and that such oxidation is associated with defective Caspase-1 and IL-1β processing ( Supplementary Fig. 10c ). Based on the results, we conclude that H 2 O 2 -mediated inflammasome inhibition is due to the oxidative inactivation of ASC and most likely other components including the oxidation-sensitive cysteine-rich caspases 42, 43 .
Considering that S.p. ΔspxB elicits a stronger inflammasome response and is cleared faster from mice (Fig. 1) , we investigated whether inflammasome activation contributes to enhanced clearance of S.p. ΔspxB using ASC −/− mice. At early time points, no ASC-dependent clearance of S.p. WT D39 is evident. However, as previously observed 25, 26 , ASC −/− mice exhibit higher bacterial burden than wild-type mice 48 h after infection ( Fig. 7a-c) . ASC-dependent clearance of S.p. WT at later rather than early time points is consistent with its H 2 O 2 -mediated inhibitory effects on inflammasomes. Hence, the elicited inflammasome response is both low and delayed. In contrast to S.p. WT, ASC-dependent clearance of S.p. ΔspxB is observed as early as 12 and 24 h after infection ( Fig. 7d-f ). Noteworthy, although carrying a higher bacterial burden-consistent with the lack of inflammasome-dependent inflammation-the ASC −/− mice exhibit lower clinical severity and body temperature changes (Fig. 7g, h) .
In addition to metabolism and H 2 O 2 production, SpxB also plays a role in other aspects of bacterial physiology 9,44,45 , which together with the modulation of inflammasomes may contribute to the in vivo attenuation of S.p. ΔspxB. Therefore, to specifically evaluate the contribution of H 2 O 2 on the infection outcome, we asked whether in vivo neutralization of H 2 O 2 by catalase could similarly increase S. pneumoniae-induced inflammation and whether this in turn could promote bacterial clearance. In agreement, when intranasally co-inoculated with catalase, S.p. WT elicits severer clinical symptoms and is cleared faster (Fig. 7i-k) , while clearance of S.p. ΔspxB is unaltered ( Fig. 7l-n) . This independently confirms that H 2 O 2 release by S. pneumoniae does inhibit innate immune activation and that this contributes to host colonization as schematically summarized in Fig. 7o .
Discussion
Here we report that in order to persist in the host S. pneumoniae interferes with a key arm of the innate immune responseinflammasome activation. We show that this feature is due to the ability of S. pneumoniae to release large quantities of hydrogen peroxide (H 2 O 2 ) thereby causing oxidative inactivation of inflammasomes in immune cells. Further, we demonstrate that inflammasome inhibition is a common feature of other high H 2 O 2 -producing bacterial species. These findings are significant. Firstly, they uncover a new mechanism of innate immune subversion by bacteria. Secondly, they highlight Inflammasomes are vital players in the eradication of bacterial pathogens 23, 25, 26 . Correspondingly, recent studies also reveal that an increasing number of pathogens are equipped with mechanisms to circumvent inflammasome activation 13, 14, 46 . Such pathogens can overcome inflammasome-dependent host defenses either by evading receptor recognition or through active mechanisms of inflammasome suppression 14 . The avoidance strategy is a stealth approach whereby pathogens disguise their 
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presence from the host for example by restricting the bioavailability of inflammasome stimuli [47] [48] [49] [50] . Active suppression on the other hand involves targeted modulation of inflammasomes by virulence factors that interact with host cell proteins 28, [51] [52] [53] [54] . The active mechanisms of inflammasome suppression reported thus far seem to require an intimate host-pathogen contact to permit the delivery of inhibitory effectors into the host cells 13, 14, 46 .
Arguably, such directed delivery of virulence factors is probably essential to ensure that immune suppression is not global but only limited to the infected and not the healthy bystander cells. In this study, we report a new mechanism of inflammasome suppression that does not require direct bacterial contact with or delivery of bacterial proteins into host cells. H 2 O 2 is a diffusible small molecule that easily crosses biological membranes and can modulate the activity of different cellular proteins. We show that by releasing H 2 O 2 into their surroundings, bacteria such as S. pneumoniae and S. oralis cause oxidative stress in host cells and that this results in suppression of different inflammasome pathways.
The demonstration that bacteria-derived H 2 O 2 inhibits inflammasomes and that this is likely a common mechanism employed by diverse bacterial species to counter the innate immune system is somewhat unexpected. Previously, several studies have linked reactive oxygen species (ROS) with the activation of the NLRP3 inflammasome [55] [56] [57] [58] . However, other studies have indicated that ROS do not trigger inflammasomes per se but support the priming phase of NLRP3 activation 25,59-61 . In fact, curiously and in agreement with the conclusions herein, it has been observed that genetic defects in ROS generation do not result in diminished inflammasome activation but rather in enhanced inflammasome activation 25, 61, 62 . On the other hand excessive generation of ROS and reactive nitrogen species by immune cells have been linked to diminished inflammasome activation 25, 43, 63, 64 .
Oxidative stress is known to result in oxidative damage of many cellular proteins 65, 66 . The data herein show that ASC oligomerization-a central node for many inflammasome pathways-is highly sensitive to oxidative inhibition. Therefore, as previously discussed 6 , although transient ROS generation might be essential for some steps such as priming, our findings support the view that oxidative stress is largely unfavourable for inflammasome activation.
Our understanding of host-microbe interactions has mostly been gleaned from studying monomicrobial infections. However, many infections such as those of the respiratory system are polymicrobial 16, 67 . In these infections, one microbe predisposes the host to colonisation by others. S. pneumoniae possibly contributes to the aetiology of polymicrobial lung colonization 16, 17 . The results here show that H 2 O 2 -mediated inflammasome inhibition not only enables bacteria to avoid invoking strong self-limiting inflammatory responses, but also to block the responsiveness of immune cells to other danger signals in co-infection setting. Thus, beyond demonstrating how S. pneumoniae and other bacteria subvert the innate Finally, the demonstration that H 2 O 2 inhibits inflammasomes advances the current knowledge beyond the conventional view of ROS as drivers of inflammation 7, 68 and highlights an underappreciated anti-inflammatory effect of ROS. The latter notion is consistent with increasing clinical and experimental evidence linking a reduction in intracellular ROS with hyperinflammation [61] [62] [63] 69 .
Methods
Ethics statement. Experiments involving humans were performed according to the recommendations of the local Research Ethics Committee of Umeå University (Regionala etikprövningsnämnden i Umeå), as approved in permit Dnr 2012-501-31M. Full informed consent was obtained from donors in compliance with the Declaration of Helsinki. Animal experiments were carried out according to the guidelines set out by the Umeå Regional Animal Ethic Committee (Umeå Regionala Djurförsöksetiska Nämnd), Approval no. A53-14.
Mice. All mice in this study were on C57BL/6 background. Asc −/− mice 27 were obtained from Genentech, South San Francisco, USA. All mice were bred at the Animal infections. Age-and sex-matched adult mice (8-20 weeks old) were anaesthetized using isoflurane with the XGI-8 gas anaesthesia system (Caliper), inoculated intranasally with 30 μl of a suspension containing 1-2 × 10 7 cfu of S. pneumoniae strain D39 wild type or D39 ΔspxB and then suspended by their teeth for 10 min to enable the infection inoculum to descend into the lungs. At different time points after infection, mice were monitored for clinical symptoms such as weight loss and temperature. Clinical severity scoring was based on an arbitrary scale from 1 to 4 where 1 represented mice with mild but visible symptoms such as slowed activity whereas 4 represented those with highest morbidity, i.e. with a combination of hunchback posture, lethargy, loose fecal pellet, ruffled fur, >25% weight loss and difficulties in breathing and movement and hence had to be euthanized. Bacterial burden in the lung was determined by plating lung homogenates on blood agar plates to determine the cfu. For in vivo analysis of cytokines, the lungs were gently disrupted in PBS to release cells from the connective tissue. Lung flushings containing extracellular fluids and cell pellets were separated by centrifugation, and extracellular fluids were analysed by ELISA.
Bacterial strains and growth conditions. S. pneumoniae D39 wild-type and D39 ΔspxB strains were provided by Jetta Bijlsma 45 Cell culture, infection and stimulation. BMDM differentiation was performed by culturing bone marrow cells in 20% conditioned L-929 culture medium for 5 days. Human PBMCs were isolated from peripheral blood using Ficoll-Paque PLUS. To measure inflammasome responses, cells were primed with 500 ng mL −1 LPS for 4.5 h and then infected with the indicated Streptococcus species for 30 min at the indicated multiplicity of infection (MOI). Thereafter, cells were further stimulated with 5 mM ATP or 1 µM nigericin for 30 min, or infected with P. aeruginosa Xen41 at MOI 20 or S. Typhimurium SL1344 at MOI 10 for 60 min. In all cases, the bacteria were centrifuged onto BMDMs at 250 × g for 5 min to ensure comparable cell contact. 100 U mL −1 catalase (except where indicated otherwise) was added simultaneously with the indicated Streptococcus species to the cell culture medium, while 50 µM H 2 O 2 was added 10 min before the addition of inflammasome −activators. For infection experiments, when cells were incubated for several hours (6-12 h), cells were infected for 60 min with S. pneumoniae, while for −further incubation the cell culture medium was replaced by medium containing 25 µg mL −1 gentamicin.
Calculation of bacterial uptake. LPS-primed BMDMs for 4.5 h were infected (or not) with S. pneumoniae WT at MOI 100 for 30 min. Cells were then infected with P. aeruginosa at MOI 20 for 1 h. Infections were synchronised by 5 min centrifugation at 250 × g. Cells were washed three times with PBS and then lysed in PBS containing 1% Triton X-100 and serial dilutions were plated on tetracyclinecontaining LA plates.
Cytokine ELISAs and LDH assay. The BD OptEIA Mouse IL-1β ELISA Set and BD OptEIA Human IL-1β ELISA Set (BD Biosciences), Mouse IL-18 ELISA Kit (MBL International), TNF alpha Human ELISA Kit (abcam) and Mouse TNF-α DuoSet (R&D Systems) were used according to the manufacturers' instructions. LDH release was determined by CytoTox-ONE Homogeneous Membrane Integrity Assay (Promega) according to the manufacturers' instructions.
Immunoblotting analysis. Supernatants from BMDMs (1.5 × 10 6 /well) maintained in serum-reduced medium (OptiMEM, Invitrogen) during stimulation were collected. Cell debris was removed by centrifugation, and proteins were precipitated by methanol-chloroform extraction. The precipitates were resuspended in 2 × Laemmli buffer, and the cells were directly lysed in 2 × Laemmli buffer. Proteins were separated on 13.5% SDS-PAGE gels and immunoblotted onto nitrocellulose membranes (Amersham). Membranes were blocked for 1 h in 1 × Roti Block (Roth) and subsequently incubated with different primary antibodies overnight. After incubation with HRP-labelled secondary antibodies, the proteins were detected using ECL substrate and X ray films. All uncropped Western blots are provided as part of the Source Data file.
Analysis of carbonylated proteins. Equal amounts of total protein lysates in 6% SDS in 20 mM Tris-HCl, pH 7.4, and 150 mM NaCl were treated with 5 µM 2,4dinitrophenylhydrazine (DNPH) in 5% trifluoroacetic acid (TFA) for 15 min. Negative controls were treated with 5% TFA without DNPH. Cell lysates were neutralised by adding 2 M Tris, pH > 11, mixed with 2 × Laemmli buffer and analysed for DNP by immunoblotting. Alternatively, the cells were lysed in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% deoxycholic acid, and 0.2% SDS containing a protease inhibitor cocktail (Roche). Protein A/G PLUS beads (Santa Cruz) with bound anti-ASC (or rat IgG control) were added to the lysates, and the mixture was incubated overnight at 4°C. The immunoprecipitates were collected, washed, resuspended in 6% SDS in 20 mM Tris, pH 7.6, with 137 mM NaCl and heated for 5 min at 70°C. The immunoprecipitated proteins were derivatized with 10 mM DNPH in 5% TFA for 15 min and neutralised using 2 M Tris, pH > 11, and buffered with 6 × Laemmli buffer. Then the proteins were analysed for DNP by immunoblotting.
ASC oligomerization. ASC oligomerization was assayed in LPS-primed cells treated with inflammasome activatiors. 3 × 10 6 cells were lysed in 20 mM Hepes, pH 7.5, 150 mM KCl, and 1% NP-40 with a protease inhibitor tablet (Roche) and sheared using a 21G × 2" needle. The cell lysates were centrifuged at 3300 × g for 10 min at 4°C, and the pellets were washed twice with 1 ml of PBS. This was followed by incubation in 2 mM suberic acid bis(N-hydroxy succinimide ester) (DSS) for 30 min at RT. After centrifugation at 3300 × g for 10 min at 4°C, the supernatants were removed and the resulting pellets were dissolved in 2 × Laemmli buffer. The proteins were separated on 10% SDS-PAGE gels and analysed by immunoblotting as described before.
Microscopy. For imaging of active Caspase-1, BMDMs were seeded on glass coverslips in 24-well plates at a density of 2.5 × 10 5 cells/well. LPS-primed cells were treated with FAM-YVAD-FMK FLICA reagent in DMSO or DMSO only for 15 min, followed by inflammasome activation. Afterwards, the cells were washed with PBS, fixed in 4% (w/v) paraformaldehyde and incubated with the rat anti-ASC (1:500) primary antibody in blocking buffer (3% (w/v) BSA and 0.1% (w/v) saponin) for 30 min. After washing, the cells were incubated with an AlexaFluor 546-conjugated secondary antibody (1:250) for 30 min, stained with DAPI before mounting and imaged using a Nikon Eclipse C1 Plus Eclipse confocal microscope. To quantify Caspase-1 activity, random image sections with at least 100 cells were counted for each condition.
